Won-Chul Lee

Won-Chul Lee

Auto-generated profile, based on publicly available information

Won-Chul Lee

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2012 in Genome Research
Verified
Journal Article
Open access
PDF file
JSJeong-Sun Seo
Jeong-Sun Seo
YJYoung Seok Ju
Young Seok Ju
WLWon-Chul Lee
Won-Chul Lee
JSJong-Yeon Shin
Jong-Yeon Shin
JLJune Koo Lee
June Koo Lee
YKYoung Tae Kim
Young Tae Kim
All cancers harbor molecular alterations in their genomes. The transcriptional consequences of these somatic mutations have not yet been comprehensively explored in lung cancer. Here we present the first large scale RNA sequencing study of lung adenocarcinoma, demonstrating its power to identify somatic point mutations as well as transcriptional variants such as gene fusions, alternative splicing events, and expression outliers. Our results reveal the genetic basis of 200 lung adenocarcinomas in Koreans including deep characterization of 87 surgical specimens by transcriptome sequencing. We identified driver somatic mutations in cancer genes including EGFR, KRAS, NRAS, BRAF, PIK3CA, MET, and CTNNB1. Candidates for novel driver mutations were also identified in genes newly implicated in lung adenocarcinoma such as LMTK2, ARID1A, NOTCH2, and SMARCA4. We found 45 fusion genes, eight of which were chimeric tyrosine kinases involving ALK, RET, ROS1, FGFR2, AXL, and PDGFRA. Among 17 recurrent alternative splicing events, we identified exon 14 skipping in the proto-oncogene MET as highly likely to be a cancer driver. The number of somatic mutations and expression outliers varied markedly between individual cancers and was strongly correlated with smoking history of patients. We identified genomic blocks within which gene expression levels were consistently increased or decreased that could be explained by copy number alterations in samples. We also found an association between lymph node metastasis and somatic mutations in TP53. These findings broaden our understanding of lung adenocarcinoma and may also lead to new diagnostic and therapeutic approaches.

22 December 2011 in Genome Research
Verified
Journal Article
Open access
PDF file
YJYoung Seok Ju
Young Seok Ju
WLWon-Chul Lee
Won-Chul Lee
JSJong-Yeon Shin
Jong-Yeon Shin
SLSeungbok Lee
Seungbok Lee
TBThomas Bleazard
Thomas Bleazard
JSJeong-Sun Seo
Jeong-Sun Seo
The identification of the molecular events that drive cancer transformation is essential to the development of targeted agents that improve the clinical outcome of lung cancer. Many studies have reported genomic driver mutations in non-small-cell lung cancers (NSCLCs) over the past decade; however, the molecular pathogenesis of >40% of NSCLCs is still unknown. To identify new molecular targets in NSCLCs, we performed the combined analysis of massively parallel whole-genome and transcriptome sequencing for cancer and paired normal tissue of a 33-yr-old lung adenocarcinoma patient, who is a never-smoker and has no familial cancer history. The cancer showed no known driver mutation in EGFR or KRAS and no EML4-ALK fusion. Here we report a novel fusion gene between KIF5B and the RET proto-oncogene caused by a pericentric inversion of 10p11.22–q11.21. This fusion gene overexpresses chimeric RET receptor tyrosine kinase, which could spontaneously induce cellular transformation. We identified the KIF5B-RET fusion in two more cases out of 20 primary lung adenocarcinomas in the replication study. Our data demonstrate that a subset of NSCLCs could be caused by a fusion of KIF5B and RET, and suggest the chimeric oncogene as a promising molecular target for the personalized diagnosis and treatment of lung cancer.

1 May 2019 in Cancer Discovery
Verified
Journal Article
Open access
PDF file
GFGrant M. Fischer
Grant M. Fischer
AJAli Jalali
Ali Jalali
DKDavid A. Kircher
David A. Kircher
WLWon-Chul Lee
Won-Chul Lee
JMJennifer L. McQuade
Jennifer L. McQuade
MDMichael A Davies
Michael A Davies
There is a critical need to improve our understanding of the pathogenesis of melanoma brain metastases (MBM). Thus, we performed RNA sequencing on 88 resected MBMs and 42 patient-matched extracranial metastases; tumors with sufficient tissue also underwent whole-exome sequencing, T-cell receptor sequencing, and IHC. MBMs demonstrated heterogeneity of immune infiltrates that correlated with prior radiation and post-craniotomy survival. Comparison with patient-matched extracranial metastases identified significant immunosuppression and enrichment of oxidative phosphorylation (OXPHOS) in MBMs. Gene-expression analysis of intracranial and subcutaneous xenografts, and a spontaneous MBM model, confirmed increased OXPHOS gene expression in MBMs, which was also detected by direct metabolite profiling and [U-13C]-glucose tracing in vivo. IACS-010759, an OXPHOS inhibitor currently in early-phase clinical trials, improved survival of mice bearing MAPK inhibitor–resistant intracranial melanoma xenografts and inhibited MBM formation in the spontaneous MBM model. The results provide new insights into the pathogenesis and therapeutic resistance of MBMs. Significance: Improving our understanding of the pathogenesis of MBMs will facilitate the rational development and prioritization of new therapeutic strategies. This study reports the most comprehensive molecular profiling of patient-matched MBMs and extracranial metastases to date. The data provide new insights into MBM biology and therapeutic resistance. See related commentary by Egelston and Margolin, p. 581. This article is highlighted in the In This Issue feature, p. 565

3 July 2011 in Nature Genetics
Verified
Journal Article
Closed access
YJYoung Seok Ju
Young Seok Ju
JKJong-Il Kim
Jong-Il Kim
SKSheehyun Kim
Sheehyun Kim
DHDongwan Hong
Dongwan Hong
HPHansoo Park
Hansoo Park
JSJeong-Sun Seo
Jeong-Sun Seo

15 April 2010 in Proteomics
Verified
Journal Article
Closed access
PDF file
BCBon‐A Cho
Bon‐A Cho
NCNam-Hyuk Cho
Nam-Hyuk Cho
CMChan‐Ki Min
Chan‐Ki Min
SKSe‐Yoon Kim
Se‐Yoon Kim
Jae-Seong YangJae-Seong Yang
Jae-Seong Yang
IKIk‐Sang Kim
Ik‐Sang Kim

1 December 2008 in Journal of Acupuncture and Meridian Studies
Verified
Journal Article
Open access
SLSoo Jae Lee
Soo Jae Lee
BLByung-Cheon Lee
Byung-Cheon Lee
CNChang Hoon Nam
Chang Hoon Nam
WLWon-Chul Lee
Won-Chul Lee
SJSeong-Uk Jhang
Seong-Uk Jhang
KSKwang-Sup Soh
Kwang-Sup Soh
Research on the Bonghan system has recently prompted great interest in the theory proposed by Bong Han Kimin in the early 1960s. In order to study the biochemical characteristics of the Bonghan system, we analyzed Bonghan ducts (BHD) on the surface of rabbit intestines and characterized the liquid in the BHD at the level of the proteome. Proteomic analysis was performed using nano LC-ESI MS/MS. Using a solution digestion technique, we identified 70 different proteins in the liquid of the BHD. We used gel-based digestion to analyze the BHD itself and our results showed the presence of 207 proteins. We used these proteins to analyze gene ontology (GO) to yield insights into biological processes, molecular functions and cellular compartmentalization. Remarkably, GO clustering showed high concentrations of proteins involved in metabolism. These proteins are not usually found in blood, lymph or blood vessels, and thus can be useful for characterizing BHD. It is worth studying their association with stem cells, especially mesenchymal stem cells, cancer cells and myeloid cells.